Access Bio Inc.

Access Bio Inc.
Stock Exchange Korea Exchange
EPS
KRW188.17
Market Cap
KRW125.58 B
Shares Outstanding
27.06 M
Public Float
-

Profile

Address
65 Cylde Road
Franklin New Jersey 08873
United States
Employees -
Website http://www.accessbio.net
Updated 09/14/2018
Access Bio, Inc. engages in the research, development, and manufacture of in-vitro diagnostic tests, biosensor, and molecular diagnostic products. The company was founded on September 27, 2002 and is headquartered in Franklin, NJ. .

Financials

View All

Young-Ho Choi
President & Chief Executive Officer
Sang-Hoon Kang
CFO, Director & Vice President